TAMMY SUTTON-CARNES: Open Payments
NPI 1700173572 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,371 in 84 payments from 13 companies in 2025. Trend: 2023 $838 · 2024 $1,783 · 2025 $3,371
Food & beverage: $3,371
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $631 |
| Vanda Pharmaceuticals Inc. | 14 | $592 |
| Teva Pharmaceuticals USA, Inc. | 9 | $359 |
| Otsuka America Pharmaceutical, Inc. | 7 | $319 |
| Axsome Therapeutics, Inc. | 4 | $282 |
| ABBVIE INC. | 11 | $262 |
| Neurocrine BioSciences, Inc. | 8 | $254 |
| E.R. Squibb & Sons, L.L.C. | 8 | $208 |
| Janssen Pharmaceuticals, Inc | 3 | $192 |
| Collegium Pharmaceutical, Inc. | 4 | $187 |
Products named: CAPLYTA, FANAPT, Auvelity, UZEDY, VRAYLAR, INGREZZA, REXULTI, HETLIOZ.
Industry payments across KY — which companies pay providers there.
